GlucoSet

company

About

GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units.

  • 11 - 50

Details

Last Funding Type
Angel
Last Funding Money Raised
€60K
Industries
Health Care,Medical,Medical Device
Founded date
Dec 21, 2011
Number Of Employee
11 - 50
Operating Status
Active

GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units.

Blood glucose levels are elevated and unstable in hospital intensive care unit (ICU) patients. This leads to costly infections, increased length of stay and mortality. The GlucoSet intravascular sensor delivers continuous and accurate information on patient's blood glucose level, enabling normalization of glucose levels, without the risk of sudden and dangerously low glucose levels.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€60K
GlucoSet has raised a total of €60K in funding over 2 rounds. Their latest funding was raised on Sep 11, 2018 from a Angel round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 11, 2018 Angel €60K 1 Nordic Angel Program Detail

Investors

Number of Lead Investors
Number of Investors
1
1
GlucoSet is funded by 1 investors. Nordic Angel Program are the most recent investors.
Investor Name Lead Investor Funding Round
Nordic Angel Program Yes Angel